## PLD: Prologis, Inc. - XLRE: Real Estate

### Executive Summary

VALUE thesis: PEG 0.54 indicates fundamental undervaluation. Consistent execution (3/4 quarters beat estimates).

- **Horizon:** 20-60 days (position)
- **Risk Profile:** Lower - fundamental undervaluation
- **Stop Type:** Fixed 2xATR ($124.61)
- **If Wrong:** Exit if fundamentals deteriorate or stop hit
- **Invalidation:** PEG > 1.5 or earnings miss

### News

- **Articles:** 10
- **Sentiment:** Bullish (Bullish: 5, Bearish: 0)

**1. Dir Bita Sells 621 ($79.2K) Of Prologis Inc [PLD]**
- Source: TradingView | 20251202T225125 | Somewhat-Bearish | Relevance: 100%
- Bita Cristina Gabriela, a Director of Prologis Inc (PLD), conducted a planned sale of 621 shares on December 1, 2025. The transaction was valued at approximately $79,240, with shares sold at a price of $127.60 each, reducing her direct holdings to 8,208 shares. This sale was executed as part of a prearranged trading plan under Rule 10b5-1.

**2. Prologis (NYSE: PLD) director reports 621-share sale under 10b5-1 plan**
- Source: Stock Titan | 20251202T223000 | Somewhat-Bearish | Relevance: 100%
- A director at Prologis (NYSE: PLD) sold 621 shares of common stock on December 1, 2025, at a price of $127.60 per share under a pre-arranged Rule 10b5-1 trading plan. Following this transaction, the director beneficially owns 8,208 shares of Prologis common stock. This insider trading activity was disclosed in a Form 4 SEC filing.

**3. BofA Analyst Bullish on Prologis (PLD)**
- Source: Finviz | 20251202T012200 | Bullish | Relevance: 100%
- BofA analyst Samir Khanal maintained a Buy recommendation on Prologis (PLD) and raised the price target from $137 to $144, citing solid third-quarter earnings for American REITs. The article also details Prologis L.P.'s recent pricing of C$700 million, 3.600% notes due in 2032, with proceeds intended for corporate expenses and debt repayment. Prologis is highlighted as a real estate company focused on logistics facilities in fast-growing markets.

**4. Prologis sells fully leased industrial assets for $53M in softening market**
- Source: The Real Deal | 20251201T203000 | Neutral | Relevance: 100%
- Prologis sold three fully leased industrial warehouses in Broward County, Florida, to an affiliate of Arnet Pharmaceuticals for $53.1 million. The deal, priced at $267 per square foot, sees Arnet Pharmaceuticals, a current tenant, acquire the Westport Business Park, which it partially finances with a $37 million loan from TD Bank. This sale occurs amidst a softening industrial market in Miami-Dade, marked by a slight increase in vacancy rates and average asking rents.

**5. Prologis, Inc. Declares Regular Cash Dividend for the Quarter Ending December 31, 2025, Payable on December 31, 2025**
- Source: MarketScreener | 20251203T230500 | Somewhat-Bullish | Relevance: 100%
- Prologis, Inc. announced a regular cash dividend of $1.01 per share for the quarter ending December 31, 2025. The dividend is payable on December 31, 2025, to stockholders of record as of December 16, 2025. The announcement was made on December 3, 2025, and includes recent news and analyst ratings concerning the company.

### Analyst Activity

**Target Signal:** NEUTRAL (Raises: 1, Lowers: 0)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-11-10 | Scotiabank | $133 | $127 | +5% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-11-10 | Scotiabank | main | Sector Perform |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_SELLING** |
| Buys | 10 ($0.00M) |
| Sells | 5 ($0.20M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 47.3% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 5 / 5 |

**Top Holders:**
- Vanguard Group Inc: 13.1% (+0.3%)
- Blackrock Inc.: 10.4% (+3.2%)
- State Street Corpora: 6.2% (-0.9%)
- JPMORGAN CHASE & CO: 4.8% (+82.6%)
- Cohen & Steers Inc.: 2.7% (-8.4%)

### Key Risks

1. Market regime shift could impact momentum names disproportionately.
2. Sector rotation risk if leadership changes from current market theme.
3. Earnings execution risk on next quarterly report.

### Catalysts

- Broader market risk-on sentiment could lift quality names.
- Year-end positioning and window dressing may support price.

### Fundamentals

PEG ratio 0.54 indicates undervaluation relative to growth. Forward P/E 44.8x stretched relative to 9% growth. Quality metrics strong (margin 35%). Institutional flow bullish (5 buying vs 5 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $119.6B |
| Beta | 1.41 |
| 52W Range | $85.35 - $131.70 |
| Short Interest | 1.8% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 0.54 |
| Forward P/E | 44.8 |
| Current P/E | 49.0 |
| YoY Growth | 9.3% |
| EPS Direction | STABLE |

### Technicals

MRS_20 deteriorating from 2.0% to 0.9% (-1.1% in 5 days), indicating relative weakness vs NASDAQ. Below STRENGTH zone by 3.1pp (needs >4.0% for momentum thesis). MRS_5 (-0.1%) diverging from MRS_20 - short-term weakness emerging. Full SMA alignment bullish (above 20/50/200 SMAs). OFD pattern: +SLN (Support).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_20 | 0.92% (CS: 60) | Neutral |
| RSI_14 | 68.0 | Neutral |
| MACD Histogram | 0.28 | Bullish |
| vs SMA20 | 1.028x | Above |
| vs SMA50 | 1.058x | Above |
| vs SMA200 | 1.151x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** VALUE

### Trade Setup

- **Entry:** $129.19
- **Stop Loss:** $124.61 (3.5% risk)
- **Target:** $138.35 (R:R method)
- **Risk/Reward:** 2.00:1
- **Target Reasoning:** VALUE thesis targets 2.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 103
- **Position Value:** $13,306.57
- **Portfolio %:** 13.31%
- **Risk Dollars:** $475.00
- **Risk Per Trade:** 0.47%
- **Modifiers:** L1 95% | L2 50% | Combined 0.47x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 0.95x |
| L2 Sector | AVOID (Zone C) | 0.50x |

*NORMAL regime with moderately constructive conditions. Fed dovish pivot expectations from weak jobs data and declining VIX suggest improving risk appetite, though narrow breadth at 51% indicates selective participation. Focus on quality sectors benefiting from rate cut expectations.*

### Earnings

**Next:** 2026-01-21 (Est: $0.68)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $0.73 | $0.82 | +11.9% |
| 2025Q2 | $0.73 | $0.61 | -16.6% |
| 2025Q1 | $0.63 | $0.63 | +0.5% |
| 2024Q4 | $0.68 | $1.37 | +100.8% |

---
*RULE-based L3 | 2026-01-06 16:37 | MRS_20*